SAkuraBONSAI: Protocol Design of a Novel, Prospective Study to Explore Clinical, Imaging, and Biomarker Outcomes in Patients with AQP4-IgG-seropositive Neuromyelitis Optica Spectrum Disorder Receiving Open-Label Satralizumab
FRONTIERS IN NEUROLOGY（2023）
Key words
biomarkers,magnetic resonance imaging (MRI),neuromyelitis optica spectrum disorder (NMOSD),optical coherence tomography (OCT),satralizumab,relapse
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined